Yahoo Finance Results
- Insider Monkey via Yahoo FinanceNov 27 18:26 PM
We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the SEC. The 13F filings show the funds' and investors' portfolio positions ...
Global Market Study on Post Herpetic Neuralgia Treatment: Growing Geriatric Population and Increased Disease Screening Rates to Fuel Adoption...Market Watch2 days ago
Pain Management Market Witness a Remarkable Growth at 6.0% CAGR Projected By 2023 | Recent Trends, Demand, Size, Share Analysis by MRFRMarket Watch3 days ago
- Market Watch4 days ago
- Thomson Reuters StreetEvents via Yahoo FinanceDec 05 4:53 AM
Maybe just -- and we have -- as you would expect, I'm not going to be able to, at this point in time, provide a lot of color on growing EBITDA for 2019. I think what I can just focus on, we ...
Endo Pharmaceuticals Inc. engages in the research and development, production, sale, and marketing of branded and generic pharmaceutical products primarily in the United States. It offers ...
Endo Pharmaceuticals is an operating company of Endo International plc, a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients through excellence in development, manufacturing and commercialization.
Endo Pharmaceuticals Inc. manufactures, markets and/or distributes more than 33 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
Endo International plc (NASDAQ / TSX: ENDP) today announced that one of its operating companies, Endo Pharmaceuticals Inc. based in Malvern, Pennsylvania, is voluntarily recalling one lot of Edex ...
The Federal Trade Commission has refiled a complaint and filed a proposed stipulated order in federal court to resolve charges that Endo Pharmaceuticals Inc.
ENDO PHARMACEUTICALS, INC. Patient Assistance Program. Patient assistance programs (PAPs) are programs created by drug companies, such as ENDO PHARMACEUTICALS, INC., to offer free or low cost drugs to individuals who are unable to pay for their medication.
Endo chose to file the complaint on January 17, 2013, and that was the date when Amneal was “brought under a court’s authority, by formal process, [and became] obligated to engage in litigation” in relation to the ‘216 patent.
Endo International plc (NASDAQ: ENDP) today announced that one of its operating companies, Endo Pharmaceuticals Inc., is voluntarily recalling two lots of Robaxin® (methocarbamol tablets, USP ...